Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2003
08/13/2003CN1117749C Insecticidal oxadiazine compounds
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117741C Heterocyclic fungicides
08/13/2003CN1117738C Endothelin antagonists
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605630 Active against drug resistant gram positive pathogens
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor
08/07/2003WO2003064415A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003WO2003064410A1 Novel 1,2,4-triazole compound
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064385A2 Delta1-pyrrolines and their use as pest control agents
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2002051819A9 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149276 Preparation of -4-thioalkybrobenzene derivatives
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149064 Pyrimidine compounds
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149031 For therapy of inflammation
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030148387 Solution phase synthesis of arylbenzoxazoles
08/07/2003US20030145394 Helium-neon excitable reticulocyte dyes derivable from halolepidines
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474718A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003CA2474594A1 Delta1-pyrrolines
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473457A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1333029A1 Pyrimidine derivatives and herbicides containing the same
08/06/2003EP1332763A1 High-density lipoprotein-cholesterol level elevating agent
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1117091C Substitute ixoxazolylthiophene compounds
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117083C Pyradazin-3-one derivatives, their use, and intermediates for their production
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/05/2003US6603023 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6602895 Inhibitors of factor Xa with a neutral P1 specificity group
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003US6602885 Viricides, organ transplants, antiarthritic agents
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602876 Adhesion receptor antagonists
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602248 Methods for repairing damaged intervertebral discs
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2079373C (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
07/31/2003WO2003062234A1 Quinoxaline compounds
07/31/2003WO2003062231A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors
07/31/2003WO2003062213A1 Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003WO2003061653A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
07/31/2003WO2003045901A3 Guanidine derivatives
07/31/2003WO2003039460A3 Mitotic kinesin inhibitors
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 647